Pleiotropy of PCSK9: Functions in Extrahepatic Tissues

被引：0
|
作者：
Yusuf Ziya Şener
Lale Tokgözoğlu
机构：
[1] Beypazarı State Hospital,Cardiology Department
[2] Hacettepe University Faculty of Medicine,Cardiology Department
来源：
Current Cardiology Reports | 2023年 / 25卷
关键词：
PCSK9; Heart; Kidney; Diabetes; Brain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：979 / 985
页数：6
相关论文
共 50 条
  • [41] PCSK9 and diabetes: is there a link?
    Momtazi, Amir Abbas
    Banach, Maciej
    Pirro, Matteo
    Stein, Evan A.
    Sahebkar, Amirhossein
    DRUG DISCOVERY TODAY, 2017, 22 (06) : 883 - 895
  • [42] Regulation of PCSK9 by nutraceuticals
    Momtazi, Amir Abbas
    Banach, Maciej
    Pirro, Matteo
    Katsiki, Niki
    Sahebkar, Amirhossein
    PHARMACOLOGICAL RESEARCH, 2017, 120 : 157 - 169
  • [43] PCSK9 Mediates Atherogenesis
    Sun, Hua
    Krauss, Ronald M.
    Teng, Ba-bie
    CIRCULATION, 2016, 134
  • [44] Clinical aspects of PCSK9
    Cariou, Bertrand
    Le May, Cedric
    Costet, Philippe
    ATHEROSCLEROSIS, 2011, 216 (02) : 258 - 265
  • [45] Epigenetic editing of PCSK9
    Le Bras, Alexandra
    LAB ANIMAL, 2025, 54 (04) : 76 - 76
  • [46] Update on PCSK9 inhibition
    Katzmann, Julius L.
    Custodis, Florian
    Schirmer, Stephan H.
    Laufs, Ulrich
    HERZ, 2022, 47 (03) : 196 - 203
  • [47] PCSK9 Association With Lipoprotein(a)
    Tavori, Hagai
    Christian, Devon
    Minnier, Jessica
    Plubell, Deanna
    Shapiro, Michael D.
    Yeang, Calvin
    Giunzioni, Ilaria
    Croyal, Mikael
    Duell, P. Barton
    Lambert, Gilles
    Tsimikas, Sotirios
    Fazio, Sergio
    CIRCULATION RESEARCH, 2016, 119 (01) : 29 - +
  • [48] The effect of PCSK9 immunization on the hepatic level of microRNAs associated with the PCSK9/LDLR pathway
    Ataei, Sarina
    Ganjali, Shiva
    Banach, Maciej
    Karimi, Ehsan
    Sahebkar, Amirhossein
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (01) : 203 - 208
  • [49] NEW GAIN OF FUNCTIONS MUTATIONS IN PCSK9 AND THEIR IMPACT IN FAMILIAL HYPERCHOLESTEROLEMIA
    AbiFadel, M.
    Rabes, J. -P.
    Guerin, M.
    Carreau, V.
    Carrie, A.
    Varret, M.
    Samson-Bouma, M. -E.
    Tosolini, L.
    Erlich, D.
    Couvert, P.
    Bonnefont-Rousselot, D.
    Bruckert, E.
    Prat, A.
    Seidah, N.
    Boileau, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 10 - 10
  • [50] High glucose effects on PCSK9 expression in aortic VSMC: role of PCSK9 inhibitors
    Barale, C.
    Melchionda, E.
    Russo, I.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S421 - S421
12345